Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations that are treatable with ablation, and updates to clinical guidelines.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2033.
The adoption rates of different ablation modalities have shifted in recent years.
How will growth vary across different ablation device categories?
In which indications and how strongly are cryoablation and IRE ablation being adopted?
What are the key ongoing clinical trials related to ablation, and what implications might they have for the interventional oncology device market?
Newer embolization technologies are seeing increasing adoption.
How will the adoption of radioembolization spheres be affected by recent clinical trials and upcoming products?
What is the adoption outlook for different embolization devices, and what factors will affect the uptake of these technologies over the forecast period?
What impact will clinical guidance have on the adoption of newer technologies in the embolization device market?
Table of contents
- Interventional Oncology Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Interventional Oncology Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Interventional Oncology Procedures, by Procedure Type, US, 2019u20132033
- Interventional Oncology Procedures, by Indication, US, 2019u20132033
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132033
- Interventional Oncology Device Market Growth, by Product Type, US, 2020u20132033
- Market Shares
- Competitive Insights
- Market Developments
- Ablation Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Ablation Procedures, by Indication, US, 2019u20132033
- Ablation Procedures, by Product Type, US, 2019u20132033
- Primary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Secondary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Kidney Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Lung Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Bone Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Pancreatic & Pelvic Cancer Ablation Procedures, by Procedure Type, US, 2019u20132033
- Ablation Disposables Market, by Product Type, US (USD), 2019u20132033
- Ablation Disposables Market Growth, by Product Type, US, 2020u20132033
- Ablation Capital Equipment Market, by Product Type, US (USD), 2019u20132033
- Ablation Capital Equipment Market Growth, by Product Type, US, 2020u20132033
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Irreversible Electroporation Ablation
- Market Shares
- Competitive Insights
- Embolization Particle Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Embolization Particle Procedures, by Indication, US, 2019u20132033
- Embolization Particle Procedures, by Product Type, US, 2019u20132033
- Primary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132033
- Secondary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132033
- Kidney Cancer Embolization Particle Procedures, US, 2019u20132033
- Embolization Particle Market, by Product Type, US (USD), 2019u20132033
- Embolization Particle Market Growth, by Product Type, US, 2020u20132033
- PVA Particles
- Microspheres
- Drug-Eluting Beads
- Radioembolization Spheres
- Market Shares
- Competitive Insights
- Accessory Device Market
- Appendix
